Effects of Clarithromycin Administration on Gastric Acid Secretion and Cytoprotection in Wistar Rats


The incidence of peptic ulcer disease in Nigeria is 28% (Ndububa and Adeyemi, 2008). Clarithromycin (CLX) is used in the treatment of peptic ulcer owing to its antibacterial effect. Whether CLX has effects on other gastrointestinal parameters that reduce peptic ulcer has not been previously investigated. Therefore the effects of CLX on gastric acid secretion, mucus secretion and gastric ulcer scores in rats were investigated. A total of 30 albino wistar rats were used for the study. Out of this number, 10 rats each were used for gastric acid secretion, mucus secretion and ulcer scores respectively. In each of these sub groups, 5 rats served as test and were treated with CLX orally and 5 rats served as control. Standard methods were used for the estimation of these parameters of gastric function. The results showed that basal gastric acid, peak acid output following histamine stimulation and mucus secretion were significantly increased (p<0.001) in CLX-treated (test) rats than in their control. Furthermore, ulcer scores were significantly reduced (p<0.001) in the CLX-treated rats than control. In conclusion, Clarithromycin administration reduced gastric ulcers in rats. This may be attributable to not only its antibiotic property but also its ability to increase gastric mucus which counteracts the aggressive effect of the acid.

Click to view file (PDF)


Alkofahi, A. and Atta A. H. (1999). "Pharmacological screening of the anti-ulcerogenic effects of some Jordanian medicinal plants in rats." J Ethnopharmacol 67: 341-345.

Alpin, R. S. and Ward, J. W. (1968). Action of hexapyronium bromide on gastric secretion in dogs and ulceration in rats. Archives international De Pharmacodyn Therapeutique.167:82-100.

Ermund, A., Schütte, A., Johansson, M.E., Gustafsson, J.K., and Hansson,G.C (2013). Studies of mucus in mouse stomach, small intestine, and colon. I. Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer's patches. Am J Physiol Gastrointest Liver Physiol. 305:341‐ 347.

Ghosh, M. N. and Schild, H. O. (1958). Continuous recording of acid gastric secretionin the rat. Br. J. Pharmac.13: 54–61.

Goldman M.P and Longworth D.L. (1993). The role of azithromycin and clarithromycin in clinical practice. Cleve Clin J Med. 60(5):359-64.

Green wood, D. (2008). Antimicrobial drugs chronicle of a twentieth century medical triumph. Oxford University Press.p239.

Iijima, K., Iwabuchi, T, Ara, N.,Koite, T., Shinkai, H., Kamata, Y., Ichikawa, T., Ishihara, K., Shimosegawa, T.(2013). Reactive increase in gastric mucus secretion is an adaptive defense mechanism against low-dose aspirin-induced gastropathy. Dig Dis Sci. 58:2266‐2274.

Julia, F. and Alfred, C. G. (2015). Am Fam Physician. 91:236-242.

Koike, T., Ohara, S., Sekine, H., Iijima, K., Kato, K., Toyota, T., and Shimosegawa, T. (2001). Increased gastric acid secretion after Helicobacter pylori eradication may be a factor for developing reflux oesophagitis. Aliment Pharmacol Ther.15(6); 813-20.

Masaki, M., Mitsushige, S., Hitomi, M., Kanno, T., Satoh, K. (2020). Clarithromycin Versus Metronidazole in First-Line Helicobacter pylori Triple Eradication Therapy Based on Resistance to Antimicrobial Agents: Meta-Analysis. J. Clin. Med. 9, 543.

Mizui, T., and Doteuchi, M. (1983). Effect of polyamines on acidified ethanol-induced gastric lesions in rats. Jpn J Pharmacol. 33:939‐945.

Ndububa D. A., Adeyemi O. J. (2008). Peptic ulcer disease in Nigeria. Journal of the Obafemi Awolowo University Medical Student’s Association. 14.

Osim, E. E., Nneli, R. O., Efem, S. E., and Etta, K. M. (1991). The effect of oral administration of aqueous extract of plantain (Musa peradisca) on gastric acid secretion in albino rats. Nigerian Journal of Physiological Sciences.7(1): 22-28.

Osim, E.E (2002). “Physiological anatomy of the digestive tract”. Elements of Gastrointestinal tract physiology pg 2. Published by Helimo Associates, 4 Fenton street Calabar Nigeria.

Periti, P.and Mazzei, T. (1999). Clarithromycin: pharmacokinetic and pharmacodynamic interrelationships and dosage regimen. J Chemother.11:11-27.

Peskar, B.M., and Maricic, N. (1998). Role of prostaglandins in gastroprotection. Dig Dis Sci 43:23S-29S.

Tan, P. V., Enow-Orok, G. E., Dimo, T., Nyasse, B. and Kimbu, S. F. (2006). Evaluation of the antiulcer and toxicity profile of Aloe buttneri in laboratory animals. Afr J Tradit Complement Altern.3:8–20.

Taweesak, T., Ryan, A.L., and Chavaboon, D.(2015). High Prevalence of Helicobacter Pylori Resistance to Clarithromycin. Asian Pac J Cancer Prev.16:8281-5.

Toma, W., Hirumu-Lima, C.A., Guerro, R.O., and Souza, A.R. (2005). Preliminary studies on Mammea Americana L (Gutti ferae) bark/latex extract point to an effective anti-ulcer effect on gastric ulcer models in mice. Phytomedicine; 12:345-50.

Toshimitsu, I., Katsunori, I., Nobuyuki, A., Tomoyuki, k., Hirohiko, S., Takafumi, I., Yayoi, K., Kazuhiko, I., and Tooru, S. (2013). Increased Gastric Mucus Secretion Alleviates Non-Steroidal Anti-Inflammatory Drug-Induced Abdominal Pain. Tohoku J. Exp. Med. 231(1).

Wangda, S., Richter, J.M., Kuenzang, P., Wangchuk, K., Choden, T.,Tenzin, K., Malaty, M.H. (2017). Epidemiology of infection in asymptomatic school children in Bhutan. Helocobacter. 22:e12439. doi:10.1111/hel.12439

World Health Organization,"WHO Model List of Essential Medicines" (PDF). 2013. Retrieved 22 April 2014.

Zainul, A.Z., Hanan, K.G., Hairani, Z., Nur, H.M.P., Nur, A.M., Anwariah, A., Mohd, R.S. (2006). Antinociceptive, anti-inflammatory and antipyretic effects of Solanum nigrumchloroform extractin animal models. J. Pharm. Soc. Jpn. 126: 1171–1178.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2020 Array